Selectively Targeting T- and B-Cell Lymphomas: A Benzothiazole Antagonist of α4β1 Integrin
摘要:
Current cancer chemotherapeutic agents clinically deployed today are designed to be indiscriminately cytotoxic, however. achieving selective targeting of cancer malignancies would allow for improved diagnostic and chemotherapeutic tools. Integrin alpha(4)beta(1), a heterodimeric cell surface receptor, is believed to have a low-affinity conformation in resting normal lymphocytes and an activated high-affinity conformation in cancerous cells, specifically T- and B-cell lymphomas. This highly attractive yet poorly understood receptor has been selectively targeted with the bisaryl urea peptidomimetic antagonist 1. However. concerns regarding its preliminary pharmacokinetic (PK) profile provided an impetus to change the pharmacophore from a bisaryl urea to a 2-arylaminobenzothiazole moiety, resulting in an analogue with improved physicochemical properties, solubility, and kidney:tumor ratio while maintaining potency (6; IC50 = 53 pM). The results presented herein utilized heterocyclic and solid-phase chemistry, cell adhesion assay, and in vivo optical imaging using the cyanine dye Cy5.5 conjugate.
The investigation of the preparation of N-(2-benzoxazolyl)aminoacids and esters from the reaction of aminoacids and esters with either 2-chlorobenzoxazole or 2-benzoxazolinone is described.
An electrochemical synthesis of 2-aminobenzoxazoles from 2-aminophenols and isothiocyanates was successfully developed in a one-pot fashion. Using inexpensive and widely available NaI and NaCl co-operatively in catalytic amounts, our electrosynthesis approach provided various 2-aminobenzoxazole products in moderate to high yields in an open-flask type undivided cell without using any external supporting
以一锅法成功开发了由 2-氨基苯酚和异硫氰酸酯电化学合成 2-氨基苯并恶唑。我们的电合成方法以催化量合作使用廉价且广泛可用的 NaI 和 NaCl,在不使用任何外部支持电解质和碱的情况下,在开放式烧瓶型未分隔电池中以中等至高产率提供各种 2-氨基苯并恶唑产品。该协议可用于以中等产率从相应的 2-苯硫酚合成 2-氨基苯并噻唑。该协议有很多好处。它不含金属且具有高度可扩展性,并在温和条件下使用廉价的介质和乙醇/水作为环保溶剂。
N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION
申请人:Aktas Bertal Huseyin
公开号:US20120115915A1
公开(公告)日:2012-05-10
Compositions and methods for inhibiting translation initiation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, and/or (4) disorders associated with viral infections, using N,N′-diarylureas and/or N,N′-diarylthiourea compounds are described.